-
FDA Approves Strattera
Eli Lilly and Company announced today that the FDA has approved Strattera for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant drug designed to treat ADHD in children, adolescents and adults. Unlike other ADD and ADHD medications such as Adderall and Ritalin, ...
-
Concentration in a Pill
One in five respondents to an informal, nonscientific online survey in the science journal Nature said they have used drugs like Ritalin and Adderall to boost their brain power, according to a CNN Health article. 1,400 people in 60 countries were polled, and the majority of those who responded said they worked in biology, physics, ...